AcneFree Clear Skin Treatments

Manufacturer
Valeant Pharmaceuticals North America LLC | Universal Packaging Systems, Inc. | Ei LLC
Effective date
2017-02-21
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
legacy-cache
Hydrated at
2026-08-02 01:19:07

Label at a glance#

ProductAcneFree Clear Skin Treatments 24 HOUR Severe Acne Clearing System
Active ingredientBENZOYL PEROXIDE
Label structure27 sections

Dosage and administration

▪ Use every morning and evening. ▪ apply a dime-size amount to damp skin and gently massage, avoiding the eye area. ▪ rinse well ▪ use wash on entire affected area one to two times daily ▪ because excessive drying of the skin my occur, start with washing once daily, then gradually increase to two times daily if needed or as directed by a doctor ▪ if bothersome dryness or peeling occurs, reduce cleansing to once a ...

Label contents#

Full prescribing information#

24 hour Severe Acne Clearing System ANTI-ACNE CLEANSING WASH

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzoyl Peroxide 2.5% w/v

Purpose

OTC - PURPOSE SECTION

Acne treatment

Use

INDICATIONS & USAGE SECTION

For the treatment of acne.

Warnings

WARNINGS SECTION

For external use only

Do not use if you

OTC - DO NOT USE SECTION

  • have sensitive skin
  • are sensitive to Benzoyl Peroxide

OTC - WHEN USING SECTION

When using this product

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • rinse right away with water if product gets in eyes
  • avoid unnecessary sun exposure and use a sunscreen
  • avoid contact with the eyes, lips and mouth
  • avoid contact with hair and dyed fabrics, which may be bleached by this product
  • skin irritation may occur, characterized by redness, burning, itching, peeling or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration.
Stop use and ask a doctor if

OTC - STOP USE SECTION

skin irritation becomes severe

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Use every morning and evening.
  • apply a dime-size amount to damp skin and gently massage, avoiding the eye area.
  • rinse well
  • use wash on entire affected area one to two times daily
  • because excessive drying of the skin my occur, start with washing once daily, then gradually increase to two times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce cleansing to once a day or every other day
  • if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of products and ask a doctor.
  • May be used on chest or back.

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, glycerin, propylene glycol, cocamidopropyl hydroxysultaine, sodium C14-16 olefin sulfonate, xanthan gum, citric acid, potassium hydroxide, methyl methacrylate/glycol dimethacrylate crosspolymer, sodium lauroyl lactylate, glycolic acid, ceramide NP, ceramide AP, phytosphingosine, cholesterol, carbomer, ceramide EOP

Questions/comments

OTC - QUESTIONS SECTION

1-800-321-4576

24 HOUR Severe Acne Clearing System CORRECTIVE TONER

SPL UNCLASSIFIED SECTION

Warnings

For external use only

Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards. Wait 10 minutes between Steps 2 and 4.

Directions

DOSAGE & ADMINISTRATION SECTION

Use every morning and evening. After cleansing, apply to entire face, avoiding the eye area. Do not rinse. May also be used on chest or back.

Ingredients

INACTIVE INGREDIENT SECTION

water, SD alcohol 40, hamamelis virginiana (witch hazel) water, sorbitol, glycerin, polysorbate 20, alcohol, glycolic acid, sodium hydroxide, aloe barbadensis leaf juice, benzalkonium chloride, bisabolol, niacinamide, panthenol, propylene glycol, disodium EDTA, chamomilla recutita (matricaria) flower extract, copper PCA, lactic acid, butylene glycol, methylisothiazolinone, sea whip extract, phenoxyethanol, citric acid, leuconostoc/radish root ferment filtrate, methylparaben, butylparaben, ethylparaben, propylparaben, isobutylparaben

Questions/comments

OTC - QUESTIONS SECTION

1-800-321-4576

24 HOUR Acne Clearing System RETINOL COMPLEX

SPL UNCLASSIFIED SECTION

Warnings

For external use only.

When using this product avoid getting into eyes. If contact occurs, rinse thoroughly with water. If skin irritation occurs, wash product off and consult physician. When first applying this product, you may experience a slight tingling sensation. This is an indication that the product is working. If sensation is prolonged or becomes unpleasant, discontinue use and consult a physician. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product.

Directions

INDICATIONS & USAGE SECTION

Apply only at night. Wait at least 10 minutes after applying Step 2 (until skin is dry), then use fingertips to massage into acne affected areas. Do not rinse off. For best results, do not use Retinol Complex at the same time as Step 3.

Ingredients

INACTIVE INGREDIENT SECTION

water, mineral oil, cetearyl alcohol, glycerin, dimethicone, glyceryl stearate, PEG-100 stearate, polysorbate 60, caprylic/capric triglyceride, cetyl alcohol, phenoxyethanol, bisabolol, retinol, xanthan gum, polysorbate 20, allantoin, C12-15 alkyl benzoate, disodium EDTA, methylparaben, cetyl palmitate, famesol, neopentyl glycol dicaprylate/dicaprate, tridecyl stearate, ceramide 3, triethanolamine, butylparaben, ethylparaben, propylparaben, isobutylparaben, cetyl triethylmonium dimethicone PEG-8 succinate, glycine sola (soybean) sterols, tridecyl trimellitate, sodium hyaluronate, methylisothiazolinone

Questions/comments

OTC - QUESTIONS SECTION

1-800-321-4576

24 HOUR Acne Clearing System MAXIMUM STRENGTH REPAIR LOTION

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzoyl Peroxide 10% w/v

Purpose

OTC - PURPOSE SECTION

Acne treatment

Use

INDICATIONS & USAGE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only

Do not use if you

  • have very sensitive skin
  • are sensitive to Benzoyl Peroxide

When using this product

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • rinse right away with water if product gets in eyes
  • avoid unnecessary sun exposure and use a sunscreen
  • avoid contact with the eyes, lips and mouth
  • avoid contact with hair and dyed fabrics, which may be bleached by this product
  • skin irritation may occur, characterized by redness, burning, itching, peeling or possibly swelling. Irritation may be reduced by using the product less frequently or in a lower concentration..

Stop use and ask a doctor if

OTC - STOP USE SECTION

skin irritation becomes severe

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Use every morning after Step 2
  • clean skin thoroughly before applying this product
  • apply to entire face avoiding the eye area
  • do not rinse
  • cover the entire affected area with a thin layer one to three times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day
  • if going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
  • IMPORTANT: For best results, do not apply Steps 3 & 4 at the same time.

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, butylene glycol, C12-15 alkyl benzoate, glycerin, glyceryl stearate, PEG-100 stearate, cetearyl alcohol, phenoxyethanol, hydroxypropyl starch phosphate, polysorbate 60, dimethicone, xanthan gum, cetyl alcohol, bisabolol, tetrasodium EDTA, ethylhexylglycerin, methylisothiazolinone, benzalkonium chloride, sea whip extract, zingiber officinale (ginger) root extract, chamomilla recutita (matricaria) flower extract, alcohol, leuconostoc/radish root ferment filtrate, methylparaben, disodium EDTA, ethylparaben, methyl methacrylate/glycol dimethacrylate crosspolymer

Questions/comments

OTC - QUESTIONS SECTION

1-800-321-4576

PRINCIPAL DISPLAY PANEL - Kit Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

AcneFree Severe 24 hour Acne Clearing System - Carton
AcneFree Severe 24 hour Acne Clearing System - Carton

AcneFree®

SEVERE

24 HOUR

Severe Acne Clearing System

AMERICA’S BEST SELLING

#1

Acne Treatment In Stores†

INCLUDES REPAIR LOTION POWERED BY ACNE-FIGHTING INGREDIENT 4XTHE CONCENTRATION LEVEL VS. PROACTIV*

When used as directed treats all stages of stubborn acne 24 hours a day

DERMATOLOGIST RECOMMENDED BENZOYL PEROXIDE

With Continuous Release Technology

CONTAINS: ANTI-ACNE CLEANSING WASH 4 FL OZ (118 mL), CORRECTIVE TONER 4 FL OZ (118 mL), MAXIMUM STRENGTH REPAIR LOTION 2 FL OZ (59 mL), RETINOL COMPLEX 1 OZ (28 g)

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0187-1611-04EA - Each0187-1611778373e2-1efa-454a-96ea-0cc6e34e4d5412020-01-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BENZOYL PEROXIDEACTIVE INGREDIENTW9WZN9A0GM4
BENZOYL PEROXIDEACTIVE MOIETYW9WZN9A0GM4
ALCOHOLINACTIVE INGREDIENT3K9958V90M4
ALKYL (C12-15) BENZOATEINACTIVE INGREDIENTA9EJ3J61HQ4
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W74
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA4
CERAMIDE 3INACTIVE INGREDIENT4370DF050B4
CERAMIDE 6 IIINACTIVE INGREDIENTF1X8L2B00J4
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1S4
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN4
CHAMOMILEINACTIVE INGREDIENTFGL3685T2X4
CHOLESTEROLINACTIVE INGREDIENT97C5T2UQ7J4
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP4
COCAMIDOPROPYL HYDROXYSULTAINEINACTIVE INGREDIENT62V75NI93W4
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O4
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86K4
EDETATE SODIUMINACTIVE INGREDIENTMP1J8420LU4
ETHYLHEXYLGLYCERININACTIVE INGREDIENT147D247K3P4
ETHYLPARABENINACTIVE INGREDIENT14255EXE394
GINGERINACTIVE INGREDIENTC5529G5JPQ4
GLYCERININACTIVE INGREDIENTPDC6A3C0OX4
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE44
GLYCOLIC ACIDINACTIVE INGREDIENT0WT12SX38S4
LEUCONOSTOC/RADISH ROOT FERMENT FILTRATEINACTIVE INGREDIENTD2QHA034584
LEVOMENOLINACTIVE INGREDIENT24WE03BX2T4
METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMERINACTIVE INGREDIENTEG97988M5Q4
METHYLISOTHIAZOLINONEINACTIVE INGREDIENT229D0E1QFA4
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T4
PEG-100 STEARATEINACTIVE INGREDIENTYD01N1999R4
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T4
PHYTOSPHINGOSINEINACTIVE INGREDIENTGIN46U9Q2Q4
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4M4
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T4
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V34
PSEUDOPTEROGORGIA ELISABETHAEINACTIVE INGREDIENTUDY3H1OUX54
SODIUM C14-16 OLEFIN SULFONATEINACTIVE INGREDIENTO9W3D3YF5U4
SODIUM LAUROYL LACTYLATEINACTIVE INGREDIENT7243K85WFO4
WATERINACTIVE INGREDIENT059QF0KO0R4
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEE4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 40 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0187-16110187-1611-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 44 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 11 · 627 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, EFFERVESCENT / ORAL460 mgExact identifier — unii candidate
88 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7GEL / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
24 equally ranked IID candidates
POLYSORBATE 60POLYSORBATE 60CAL22UVI4MGUM, CHEWING / BUCCAL5 mgExact identifier — unii candidate
13 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEEGRANULE, FOR SUSPENSION / ORAL450 mgExact identifier — unii candidate
29 equally ranked IID candidates
EDETATE SODIUMEDETATE SODIUMMP1J8420LUCAPSULE / ORAL1 mgExact identifier — unii candidate
12 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY, METERED / NASAL240 mgExact identifier — unii candidate
81 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPCONCENTRATE / ORAL5.3 mg/1mlExact identifier — unii candidate
88 equally ranked IID candidates
CHOLESTEROLCHOLESTEROL97C5T2UQ7JINJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL7 mgExact identifier — unii candidate
10 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION / OPHTHALMIC2 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
EDETATE SODIUMEDETATE SODIUMMP1J8420LUEMULSION / OPHTHALMIC0.02 %w/vExact identifier — unii candidate
12 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TLIQUID / ORAL162 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION / TOPICAL0.24 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION, EXTENDED RELEASE / ORAL2000 mgExact identifier — unii candidate
75 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7LIQUID / NASAL0.2 mg/1mlExact identifier — unii candidate
24 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / IRRIGATION2 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSUSPENSION / AURICULAR (OTIC)NAExact identifier — unii candidate
79 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNSUSPENSION / TOPICAL2.01 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / TRANSDERMAL7360 mgExact identifier — unii candidate
59 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / RECTAL0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii candidate
59 equally ranked IID candidates
EDETATE SODIUMEDETATE SODIUMMP1J8420LUINJECTION / INTRAVENOUS0.01 %w/vExact identifier — unii candidate
12 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSUSPENSION / ORAL30 mgExact identifier — unii candidate
77 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSUSPENSION / RESPIRATORY (INHALATION)0.03 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE, EXTENDED RELEASE / ORAL265 mgExact identifier — unii candidate
75 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / TRANSDERMAL49.37 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, COATED / ORAL0.21 mgExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGEL / TOPICAL24 mgExact identifier — unii candidate
79 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION/ DROPS / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESOLUTION / ORAL84 mgExact identifier — unii candidate
29 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPCAPSULE, EXTENDED RELEASE / ORAL101 mgExact identifier — unii candidate
88 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INTRALESIONAL0.15 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION/ DROPS / TOPICAL0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET / SUBLINGUAL1.23 mgExact identifier — unii candidate
21 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS608 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL2 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPGEL / TOPICAL1 mgExact identifier — unii candidate
88 equally ranked IID candidates
EDETATE SODIUMEDETATE SODIUMMP1J8420LUSOLUTION / OPHTHALMIC0.1 %w/vExact identifier — unii candidate
12 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT, AUGMENTED / TOPICAL714 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED / ORAL25 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / RESPIRATORY (INHALATION)0.08 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPTABLET, FILM COATED / ORAL42 mgExact identifier — unii candidate
88 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KLIQUID / ORAL0.5 mg/1mlExact identifier — unii candidate
77 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET / ORALNAExact identifier — unii candidate
20 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPPOWDER / ORAL840 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / RESPIRATORY (INHALATION)8 mgExact identifier — unii candidate
88 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / OPHTHALMIC6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNTABLET, ORALLY DISINTEGRATING / ORAL9 mgExact identifier — unii candidate
20 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SUSPENSION/ DROPS / AURICULAR (OTIC)0.02 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION / NASAL100 mg/100mlExact identifier — unii candidate
77 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL / TOPICAL561 mgExact identifier — unii candidate
59 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SUSPENSION / INTRAMUSCULAR1 mgExact identifier — unii candidate
79 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, FILM COATED / ORAL4 mgExact identifier — unii candidate
77 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION, SOLUTION / SUBCUTANEOUS2 mgExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii candidate
81 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION/ DROPS / AURICULAR (OTIC)0.04 %w/wExact identifier — unii candidate
88 equally ranked IID candidates
POTASSIUM HYDROXIDEPOTASSIUM HYDROXIDEWZH3C48M4TSOLUTION / ORALADJ PHExact identifier — unii candidate
13 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCREAM / TOPICAL1720 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXJELLY / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION / AURICULAR (OTIC)0.01 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXOINTMENT / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
be7afad7-f8e2-4b21-908c-74721e2c0d7107d2a46d-7f50-4c17-8e18-8955376134d32017-02-21WarningsExact identifier
spl set id: 07d2a46d-7f50-4c17-8e18-8955376134d3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.